1. Home
  2. FLY vs INDV Comparison

FLY vs INDV Comparison

Compare FLY & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FLY

Firefly Aerospace Inc.

HOLD

Current Price

$39.93

Market Cap

5.5B

Sector

Industrials

ML Signal

HOLD

Logo Indivior PLC

INDV

Indivior PLC

HOLD

Current Price

$37.97

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLY
INDV
Founded
2017
N/A
Country
United States
United States
Employees
1409
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.7B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
FLY
INDV
Price
$39.93
$37.97
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$38.88
N/A
AVG Volume (30 Days)
5.5M
1.9M
Earning Date
05-04-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
8100.00
EPS
N/A
0.69
Revenue
N/A
$1,239,000,000.00
Revenue This Year
$174.79
N/A
Revenue Next Year
$66.73
N/A
P/E Ratio
N/A
$56.35
Revenue Growth
N/A
4.29
52 Week Low
$16.00
$11.07
52 Week High
$55.00
$41.00

Technical Indicators

Market Signals
Indicator
FLY
INDV
Relative Strength Index (RSI) 59.71 62.08
Support Level $18.95 $29.71
Resistance Level $48.28 N/A
Average True Range (ATR) 3.79 1.54
MACD -0.05 0.27
Stochastic Oscillator 89.20 63.98

Price Performance

Historical Comparison
FLY
INDV

About FLY Firefly Aerospace Inc.

Firefly Aerospace Inc is a space and defense technology company with an established track record of success providing comprehensive mission solutions to national security, government, and commercial customers. The company develops and provides space and defense technologies, including launch vehicles and spacecraft systems, supporting launch, transit, and in-orbit operations for government, commercial, and national security customers. It has only one operating segment. The majority of the company's revenue is derived from Spacecraft Solutions.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: